Coherus BioSciences Inc (CHRS) — Financial Flexibility Index
Coherus BioSciences Inc (CHRS) has a Financial Flexibility Index of -0.10x as of December 2025. Free cash flow of $-19.72 Million (operating CF $-19.72 Million minus capex $0.00) represents 0% of total liabilities ($197.33 Million). Also explore Coherus BioSciences Inc (CHRS) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Coherus BioSciences Inc Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Coherus BioSciences Inc across 14 annual periods. Check Coherus BioSciences Inc (CHRS) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Coherus BioSciences Inc (2012–2025)
Year-by-year free cash flow to debt coverage for Coherus BioSciences Inc. For the full company profile including market capitalisation, see Coherus BioSciences Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.70x | $-138.51 Million | $-138.51 Million | $197.33 Million | ▼ -1893.6% |
| 2024 | -0.04x | $-20.44 Million | $-20.44 Million | $580.52 Million | ▲ +83.4% |
| 2023 | -0.21x | $-174.60 Million | $-174.88 Million | $823.03 Million | ▲ +45.1% |
| 2022 | -0.39x | $-239.09 Million | $-241.12 Million | $618.26 Million | ▼ -522.3% |
| 2021 | -0.06x | $-36.14 Million | $-37.43 Million | $581.61 Million | ▼ -121.6% |
| 2020 | 0.29x | $161.38 Million | $154.15 Million | $560.67 Million | ▲ +111.9% |
| 2019 | 0.14x | $41.25 Million | $28.36 Million | $303.71 Million | ▲ +111.8% |
| 2018 | -1.15x | $-158.48 Million | $-159.27 Million | $138.06 Million | ▲ +22.5% |
| 2017 | -1.48x | $-195.71 Million | $-200.29 Million | $132.08 Million | ▲ +4.2% |
| 2016 | -1.55x | $-246.03 Million | $-252.54 Million | $159.13 Million | ▼ -233.0% |
| 2015 | -0.46x | $-101.83 Million | $-107.99 Million | $219.31 Million | ▼ -165.4% |
| 2014 | -0.17x | $-21.08 Million | $-23.93 Million | $120.46 Million | ▼ -199.5% |
| 2013 | 0.18x | $15.80 Million | $15.42 Million | $89.83 Million | ▲ +118.5% |
| 2012 | -0.95x | $-16.47 Million | $-18.25 Million | $17.34 Million | — |